EGREMONT LTD

Company number 13055043 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

EGREMONT LTD - Analysis Report

Company Number: 13055043

Analysis Date: 2025-07-29 13:23 UTC

Financial Health Assessment for EGREMONT LTD


1. Financial Health Score: C

Explanation:
EGREMONT LTD demonstrates a fragile financial position with a marginal improvement in net assets after years of negative equity. The company’s micro-entity status and relatively small scale limit complexity but also constrain capital and liquidity resources. While the company is not currently in distress, its heavy reliance on fixed assets and persistent net current liabilities are symptoms of financial strain. The score reflects a borderline healthy state requiring attentive management.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £464,546 Represents substantial investment in property or equipment; a solid long-term asset base.
Current Assets £12,536 Very low liquidity; cash and short-term assets insufficient to cover immediate obligations.
Current Liabilities £470,846 High short-term debts; a critical red flag for liquidity risk.
Net Current Assets -£458,310 Indicates working capital deficit; unable to cover short-term debts with available assets.
Total Assets Less CL £6,236 Slightly positive after deducting current liabilities; marginal buffer against insolvency.
Net Assets (Equity) £6,236 Marginally positive shareholder funds after years of negative equity; slight recovery noted.
Share Capital £1 Nominal paid-up capital, typical for micro companies but limits ability to absorb losses.
Employee Count 1 Very small operational scale, likely owner-managed; limited operational complexity.

3. Diagnosis: Financial Condition Analysis

  • Liquidity Symptoms: The company suffers from a pronounced working capital deficiency, with current liabilities vastly exceeding current assets. This “symptom” signals strain in meeting short-term obligations, akin to a patient with poor blood circulation—urgent attention is necessary to avoid “collapse” or insolvency.

  • Asset Structure: The balance sheet is heavily weighted towards fixed assets, suggesting the business operates primarily in real estate (confirmed by SIC code 68209). The fixed assets are stable and unchanged over three years, indicating no recent disposals or acquisitions.

  • Equity Recovery: After sustained negative equity in 2022 and 2023 (net liabilities around £1,137), the company has returned to modest positive net assets (£6,236) in 2024. This signals a mild improvement or capital injection but remains precarious.

  • Scale and Operations: The company’s micro classification and single employee suggest minimal operational complexity but also limited income streams. The director is the sole significant controller, which simplifies governance but concentrates risks.

  • Risk Factors: Persistent current liabilities exceeding current assets pose a risk of liquidity distress. Without a healthy cash flow or working capital buffer, the company risks “financial shock” if short-term creditors demand repayment.


4. Recommendations: Prescriptions for Financial Wellness

  1. Improve Liquidity Management:

    • Increase current assets by accelerating receivables collection or maintaining cash reserves.
    • Renegotiate payment terms with creditors to reduce immediate liabilities.
    • Consider short-term financing options to bridge working capital gaps.
  2. Review Debt Levels:

    • Assess the nature of current liabilities to identify any non-essential or high-cost debts that can be refinanced or reduced.
    • Explore longer-term financing to convert short-term liabilities into more manageable obligations.
  3. Enhance Equity Base:

    • Consider additional capital injection or shareholder loans to strengthen the balance sheet.
    • Retain profits within the business to rebuild reserves.
  4. Operational Efficiency:

    • Given the micro scale, ensure lean operations to minimize overheads.
    • Explore new revenue streams or asset utilization strategies to boost income.
  5. Regular Financial Monitoring:

    • Implement monthly cash flow forecasting to detect early warning signs of distress.
    • Prepare contingency plans for liquidity emergencies.

Medical Analogy Summary:
EGREMONT LTD currently exhibits “symptoms of financial distress,” primarily due to liquidity weakness and working capital deficits. The "patient" shows signs of mild recovery with positive net assets but remains vulnerable to “financial shocks.” Proactive management of short-term obligations and strengthening of the equity “immune system” are essential to restore robust financial health.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.